LH

Lori Hu

Managing Director at Vertex Ventures HC

San Francisco Bay Area

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $200,000.00
  • Target Investment:

    $150,000.00

Work Experience

  • Managing Director

    2015

    Vertex Ventures HC (www.vertexventureshc.com) is part of a global venture fund network under Vertex Venture Holdings, a subsidiary of Temasek Holdings, with offices in San Francisco and Boston. Vertex Ventures HC invests globally focusing on biotech and medical technologies with $550M assets under management.

  • Board Observer

    2023

2022

  • Board Director

    2022

  • Board Director

    2018

    Glycan-mediated immune regulation to treat cancer and inflammatory diseases

  • Board Director

    2022

    NK cell therapy

  • Board Director

    2021

    Miniaturized neuromodulation

2019 - 2024

  • Board Director

    2019 - 2024

    Clinical-stage targeted oncology company (NASDAQ: ELEV)

2015 - 2022

  • Board Observer

    2015 - 2022

  • Board Director

    2018 - 2020

    Precision neuroscience co (now part of Neumora)

2014 - 2015

  • VC Associate

    2014 - 2015

    Evaluate early-stage healthcare and biotech opportunities for SR One, GlaxoSmithKline's independent corporate healthcare venture capital fund